| |
 |
Altana Pharma AG Patents |
|
Assignee: Altana Pharma AG
Address: Konstanz, DE
No. of patents: 82
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 6846821 |
Tetrahydrothiopy ranphthalazinone derivatives as PDE4 inhibitors |
January 25, 2005 |
| The compounds of formula (I) in which R1, R2, A and Ar have the meanings as given in the description are novel effective PDE4 inhibitors. ##STR1## |
| 6818651 |
(Dihydro) isoquinoline derivatives as phosphodiesterase inhibitors |
November 16, 2004 |
| 3,4-Dihydroisoquinoline and isoquinoline compounds of formula I, in which Ar represents a phenyl raidcal of the formulae IIa, IIb or IIc are novel effective PDE7 inhibitors. |
| 6818642 |
Benzylaminopyrimidines |
November 16, 2004 |
| Benzylaminopyrimidine compounds of a certain general formula I, in which the substituents and symbols are as defined in the description, are suitable for controlling Helicobacter bacteria. |
| 6815557 |
Tryptase inhibitors |
November 9, 2004 |
| Compounds of formula (I), in which M, A1, A2, K1 and K2 have the meanings as indicated in the description are novel active tryptase inhibitors. |
| 6812349 |
Process and intermediates for the preparation of imidazopyridines |
November 2, 2004 |
| The invention relates to compounds of formula (2) in which R1, R2, R3 and R4 have the meanings indicated in the description, their preparation and their further reaction to give compounds of formula (1), in which A.sub.1, A.sub.2 and R4 have the meanings indicated in the description. The |
| 6787533 |
Process for R-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregna,4-dien-11.beta. |
September 7, 2004 |
| R-epimer enrichment of 16,17-acetal derivatives of 21-acyloxy pregna-1,4-dien-11beta,16alpha,17alpha-triol-3,20-dione derivatives is effected by fractional crystallization. |
| 6780881 |
Freeze-dried pantoprazole preparation and pantoprazole injection |
August 24, 2004 |
| Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium hydroxide and/or sodium carbonate are disclosed. The preparations have advantageous properties |
| 6767901 |
Ciclesonide contained pharmaceutical composition for application to mucosa |
July 27, 2004 |
| The present invention provides a pharmaceutical composition for application to the mucosa to be used in drug therapy comprising a water-insoluble and/or water-low soluble substance, ciclesonide, and an aqueous medium, and having an osmotic pressure of less than 290 mOsm. This composition |
| 6756371 |
Phthalazinone derivatives as PDE4 inhibitors |
June 29, 2004 |
| The compounds of formula (I) in which R1, R2, A, B and Ar have the meanings as given in the description are novel effective PDe4 inhibitors ##STR1## |
| 6737243 |
Determination of the hydrophobic pulmonary surfactant protein SP-C |
May 18, 2004 |
| Methods for determining the strongly hydrophobic pulmonary surfactant protein SP-C, SP-C specific antibody and a reagent kit for carrying out the methods are described. |
| 6716990 |
Process and intermediates for the preparation of imidazopyridines |
April 6, 2004 |
| The invention relates to compounds of formula (2) in which R1, R2, R3 and R4 have the meanings indicated in the description, their preparation and their further reaction to give compounds of formula (1), in which A.sub.1, A.sub.2 and R4 have the meanings indicated in the description. The |
| 6696461 |
Tricyclic imidazopyridines |
February 24, 2004 |
| Compounds of formula (I) in which the substituents as defined in the description are useful for preventing and treating gastrointestinal disorders. ##STR1## |
| 6686379 |
Salt form of pantoprazole |
February 3, 2004 |
| The invention relates to the dihydrate of the magnesium salt of pantoprazole. |
| 6673786 |
Tryptase inhibitors |
January 6, 2004 |
| A compound of formula I ##STR1##in which M, A1, A2, A3, A4, A5, A6, B1, B2, B3, B4, B5, B6, K1, and K2 are defined herein and are novel effective tryptase-inhibitors. |
| 6653477 |
Imidazopyridin-8-ones |
November 25, 2003 |
| Compounds of formula (I), in which the substituents have the meanings mentioned in the description, are valuable intermediates for preparing active compounds for the prevention and treatment of gastrointestinal diseases. ##STR1## |
| 6630483 |
Phenanthridine-N-oxides |
October 7, 2003 |
| N-oxides of the compounds of formula (I) in which R1 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy or completely or predominantly fluorine-substituted 1-4C-alkoxy, R2 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy or completely or predominantl |
| 6624181 |
Synergistic combination |
September 23, 2003 |
| The invention relates to the combined administration of PDE inhibitors and .beta..sub.2 adrenoceptor agonists for the treatment of respiratory tract disorders. |
| 6613769 |
Tryptase inhibitors |
September 2, 2003 |
| The invention relates to bifunctional tryptase inhibitors of formula (I) ##STR1##wherein H1 and H2 comprise a Q group and L is a linker of formula ##STR2##and the conformation of the H1, H2 and L groups is such that the groups are separated by a distance of from 20 to 45 .ANG.. Pharmaceu |
| 6607742 |
Suppository composition which is a spray-dried suspension of an acid-labile proton pump inhibito |
August 19, 2003 |
| Acid-labile active compounds are prepared in suppository form, particularly for rectal administration. |
| 6599752 |
Process for separating and analyzing hydrophobic proteins using thin layer chromatography |
July 29, 2003 |
| This-layer chromatography is used to separate, identify and quantity hydrophobic protein, hydrophobic protein fragment, hydrophobic modified protein and hydrophobic peptide. A method is thus provided for determination of proteins and peptides which, due to their low solubility in an |
| 6569453 |
Administration form comprising an acid-labile active compound |
May 27, 2003 |
| An administration form for acid-labile active compounds are described. The administration forms have no enteric layers and are suitable for oral administration. |
| 6544993 |
Tetrahydrothiopyranphthalazinone derivatives as PDE4 inhibitors |
April 8, 2003 |
| The compounds of formula (I) in which R1, R2, A and Ar have the meanings as given in the description are novel effective PDE4 inhibitors. ##STR1## |
| 6544250 |
Blind clinical trial device |
April 8, 2003 |
| The present invention relates to a device for blinding the administration of nonsolid pharmaceutical presentations. The device is in particular an opaque container which has at least two attachments, one of which is intended for connection to a dispenser for the pharmaceutical presen |
| 6538005 |
Phenanthridine-N-oxides with PDE-IV inhibiting activity |
March 25, 2003 |
| The N-oxides of the compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, arm novel active bronchial therapeutics. ##STR1## |
| 6534519 |
Phenanthridine-N-oxides with PDE-IV inhibiting activity |
March 18, 2003 |
| The N-oxides of the compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, are novel active bronchial therapeutics. ##STR1## |
| 6534518 |
Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity |
March 18, 2003 |
| Compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, are novel active bronchial therapeutics. ##STR1## |
| 6531493 |
3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benzamide in the treatment of m |
March 11, 2003 |
| The invention relates to the novel use of 3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benzamide , a pharmacologically tolerable salt thereof or its N-oxide in the treatment of multiple sclerosis. |
| 6503923 |
Haloalkoxy imidazonaphthyridines |
January 7, 2003 |
| Compounds of formula I ##STR1##in which R1, R2, R3, R4a, R4b, R5a, R5b, R6 and R7 have the meanings indicated in the specification, and their pharmacologically tolerable salts are useful for preventing and/or treating gastrointestinal diseases. |
| 6498173 |
Synergistic combination comprising roflumilast and a pde-3 inhibitor |
December 24, 2002 |
| Combinations of N-(3,5-dichloropyrid)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide, its pharmacologically tolerable salts or its N-oxide, with PDE.sub.3 inhibitors, and methods of use thereof, are disclosed for therapeutic purposes. |
| 6479514 |
Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity |
November 12, 2002 |
| Compounds of formula (I) in which the substituents and symbols have the meanings indicated in the description, are suitable for the control of Helicobacter bacteria. ##STR1## |
| 6479505 |
6-arylphenanthridines with PDE-IV inhibiting activity |
November 12, 2002 |
| Compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and Ar have the meanings indicated in the description, are novel active bronchial therapeutics. ##STR1## |
| 6476025 |
Phenylphennanthridines with PDE-IV inhibiting activity |
November 5, 2002 |
| Compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51, R6, R13 and R20 have the meaning indicated in the description, are novel active bronchial therapeutics ##STR1## |
|
|
|
